- Journal Archives
- Volume 16
- Volume 15
- Volume 14
- Volume 13
- Volume 12
- Volume 11
- Volume 10
- Volume 9
- Volume 8
- Volume 7
- Volume 6
- Volume 5
- Volume 4
- Volume 3
- Volume 2
- Volume 1
Currently viewing the tag: "health care"
Patent Eligibility Symposium Wrap-Up
On Friday, Jan. 24, 2014, JETLaw hosted its 2013-2014 symposium, Patents 101: From Computer Code to Genetic Codes, focusing on what, exactly, is eligible for patent protection. Chief Judge Randall Rader of the Federal Circuit delivered the keynote address, and panels addressed software patents, gene patents, and principles of patent [...]Continue Reading →
Controversy has surrounded health care reform at least since the 2008 presidential elections, and it has not died down since President Obama signed the health care bill into law back in March. The Tea Party, perhaps the loudest opponent to this law, has consistently argued that Congress exceeded its constitutional power in passing the [...]Continue Reading →
Reminiscent of music industry tycoons, producers of “The Hurt Locker” sue BitTorrent users for illegal downloading of the film.
Gary McKinnon, computer hacker that breached Department of Defense and NASA websites, fights extradition to the United States.
Woman’s war against Adobe demonstrates the advantages of Continue Reading →
I respect the time, effort, and money that pharmaceutical companies devote to drug research and development, and advertising the drugs that are ultimately developed is an inevitable part of the research and development [...]Continue Reading →
In the news . . .
Ukrainian law prohibiting unmarried couples from adopting children bars Elton John and longtime partner David Furnish from adopting 14-month-old, HIV-stricken child.
PCs and iPhones with text-to-speech applications for speech-impaired denied coverage by Medicare and private health insurers due to other non-medical uses.Continue Reading →
Pfizer offered a major “mea culpa” last week when it agreed to pay $2.3 billion in fines for the “largest combined federal and state health care fraud settlement in the history of the Department of Justice.” The pharmaceutical company has ended up in this less than esteemed position as a result of its [...]Continue Reading →
Over the Counter but Under the Radar: Direct-to-Consumer Genetic Tests and FDA Regulation of Medical Devices
On May 6, 2009 By JETLaw May 6, 2009
Look for Over the Counter but Under the Radar: Direct-to-Consumer Genetic Tests and FDA Regulation of Medical Devices in the Spring 2009 issue (Vol. 11, No. 3) of the Vanderbilt Journal of Entertainment and Technology Law. The Abstract for the Note follows:
Direct-to-consumer genetic tests are laboratory-developed tests that are marketed and sold directly to consumers. [...]Continue Reading →
Recent Blog Posts
- Nickelodeon’s Kids v. Google
- Ivanpah Solar Plant’s Firey Clash of Environmental Objectives
- The Silk Road: An Insight Into the Future of Internet Regulation?
- JETLaw Symposium on Intellectual Property Tomorrow
- San Jose Strikes Out Again in Suit Against MLB
- National Marine Fisheries Service Enters the Electronic Age
Tagsadvertising antitrust Apple books career celebrities contracts copyright copyright infringement courts creative content criminal law entertainment Facebook FCC film/television financial First Amendment games Google government intellectual property internet JETLaw journalism lawsuits legislation media medicine Monday Morning JETLawg music NFL patents privacy progress publicity rights radio social networking sports Supreme Court of the United States (SCOTUS) technology telecommunications trademarks Twitter U.S. Constitution